Sanofi Sees More Than 30 Billion Euros in Sales From New Drugs

Sanofi (SAN), the French drugmaker that fired Chief Executive Officer Chris Viehbacher last month, said it may get 30 billion euros ($37.6 billion) in sales from new drugs it plans to introduce.

Sanofi may get approvals for as many as 18 products between 2014 and 2020, which cumulatively may generate more than 30 billion euros over the first five years of sales, the Paris-based company said in a statement today. Sanofi will be presenting more details on its drug development to analysts at a...